Treatment of Inflammatory Bowel Disease with Biologics

149

Caviglia et al. [^85

]

CD: 29

Retrospective

CD: 69% [median 1.3 (0.4–2.5) years]

Not reported

Not reported

• 
  

(100% CD and 33% UC with concomitant IMM)

UC: 9

UC: 56% [median 0.5 (0.3–1.3) years]

Ciria et al. [

86

]

CD:24

Retrospective (% of concomitant IMM not reported)

35% (median follow-up 1.7 years)

Absence of mucosal healing

Type of IBD

• 
  

UC: 10

Farkas et al. [^87

]

CD:41

Retrospective (85% CD and 73% UC with concomitant IMM)

CD: 78% (0.4 year)

Nil identified

Clinical remission

81% (CD)

UC:22

UC: 59% (0.6 years)

Mucosal healing

54% (UC)

Luppino et al. [^88

]

CD: 21UC: 10

Retrospective (100% with concomitant IMM)

42% (median time to relapse 1.5 years)

Longer disease duration

Not available

80%

Marino et al. [^89

]

CD: 8UC: 2

Retrospective (20% with concomitant IMM)

CD: 75% (mean 1.2 (SD ± 0.7) years]

Not available

Not available

100%

UC: 0% (mean 1.7 years)

(continued)

10 Cessation offlBiologics: Can It BeflDone?